Lagging behind rapid changes to state laws, societal views, and medical practice is the scientific investigation of cannabis's impact on the human brain. While several brain imaging studies have contributed important insight into neurobiological alterations linked with cannabis use, our understanding remains limited. Here, we sought to delineate those brain regions that consistently demonstrate functional alterations among cannabis users versus non-users across neuroimaging studies using the activation likelihood estimation meta-analysis framework. In ancillary analyses, we characterized task-related brain networks that co-activate with cannabis-affected regions using data archived in a large neuroimaging repository, and then determined which psychological processes may be disrupted via functional decoding techniques. When considering convergent alterations among users, decreased activation was observed in the anterior cingulate cortex, which co-activated with frontal, parietal, and limbic areas and was linked with cognitive control processes. Similarly, decreased activation was observed in the dorsolateral prefrontal cortex, which co-activated with frontal and occipital areas and linked with attention-related processes. Conversely, increased activation among users was observed in the striatum, which coactivated with frontal, parietal, and other limbic areas and linked with reward processing. These meta-analytic outcomes indicate that cannabis use is linked with differential, region-specific effects across the brain.
Introduction
Cannabis, the flowering plant genus that includes three species, C. sativa, C. indica, and C. ruderalis, contains psychotropic and non-psychotropic compounds, including delta-9-tetrahydracannabinol (THC) and cannabidiol (CBD). These compounds interact with endogenous cannabinoid receptors distributed throughout the central nervous system, with particularly high receptor densities found in the thalamus, cingulate cortex, and primary and supplementary motor areas (Freund et al., 2003; Howlett et al., 2002) . In 2015, there were an estimated 22.2 million past-month cannabis users in the United States (US), a number expected to continue rising in the coming years (Substance Abuse and Mental Health Services Administration, 2016). As of September 2017, 29 states within the US and the District of Columbia have enacted legislation that permits cannabis use for the treatment of various medical conditions, with several states even permitting recreational use. Lagging behind these rapid changes to state laws, as well as societal views and medical practice, is insight into the cognitive, behavioral, and neurobiological consequences of cannabis use. Deeper understanding of cannabis's impact on brain functioning is important for informed decision-making about its use.
Functional neuroimaging modalities -including functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) -provide a means to examine the effects of substance use and abuse on the human brain (Jia et al., 2011; Sutherland et al., 2015 Sutherland et al., , 2016 Volkow et al., 2013) . Regarding cannabis, some insights into region-specific effects are beginning Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing to emerge. Specifically, previous studies suggest attenuated activity among users in brain regions supporting executive functions, such as cognitive control, error processing, and learning, yet enhanced activity in regions supporting reward processing. For example, Hester et al. (2009) examined the neural correlates of error processing among cannabis users employing a modified Go/No-Go response inhibition task. Those authors observed behavioral deficits in error awareness (but not error commission) among users versus non-users, and that more severe reductions in anterior cingulate cortex (ACC) activation were associated with greater error awareness deficiencies. Similarly, Jager et al. (2007) documented reduced activation in the dorsolateral prefrontal cortex (DL-PFC), among other regions, in abstinent cannabis users completing an associative memory paradigm, such that cannabisrelated reduced activation within prefrontal regions was more pronounced during associative learning relative to retrieval task phases. In another example, Nestor et al. (2010) used a monetary incentive delay paradigm to examine reward anticipation and evaluation among cannabis users. Those researchers reported increased ventral striatum responding during reward anticipation among users versus non-users. Importantly, cannabis-use patterns (i.e. lifetime joints consumed) were positively correlated with increased striatal activation, providing evidence for heightened sensitivity to reward-predictive stimuli with increasing exposure. Moving forward, an important challenge facing the field is to synthesize findings from functional neuroimaging studies on cannabis use to establish aggregate patterns of neurobiological changes associated with non-acute exposure.
Towards this goal, several narrative reviews have sought to summarize the neural, cognitive, and behavioral consequences of cannabis use (Bhattacharyya et al., 2012a; Bhattacharyya and Sendt, 2012; Bossong et al., 2014; Kowal et al., 2013; MartinSantos et al., 2010; Wrege et al., 2014) . En masse, these reviews provide variant yet complimentary perspectives. Specifically, some reports have advocated that cannabis use has detrimental effects on cognitive processes, such as attention and decisionmaking (Bhattacharyya et al., 2012a; Martin-Santos et al., 2010; Wrege et al., 2014) , which have been ascribed to decreased activation within frontal and prefrontal regions, including the ACC (Eldreth et al., 2004; Gruber and Yurgelun-Todd, 2005; Hester et al., 2009 ) and DL-PFC (Bolla et al., 2005) . Others have focused on salience processing and impulsiveness among cannabis users, highlighting enhanced activation within reward circuits (Bhattacharyya et al., 2012a; Wrege et al., 2014) , including the striatum (Bhattacharyya et al., 2012b ). Despite these highlevel interpretations, results from specific studies have been inconsistent, with several reports suggesting discordant outcomes (Volkow et al., 2016) . For example, Gruber et al. (2012) used a multi-source inference task to examine impulsive-behavior inhibition among cannabis users. Using a region-of-interest (ROI) approach, those authors identified increased ACC activation among users, despite comparable behavioral performance to non-using controls. In another example, Martz et al. (2016) demonstrated decreased striatal responsiveness among young adult users during reward anticipation relative to controls in a monetary incentive delay task. These variant, and at times contradicting outcomes may not be surprising when one considers the limited, yet growing corpus of functional neuroimaging studies that have examined the non-acute effects of cannabis (e.g. longterm recreational use) on brain function. Accordingly, unbiased procedures that assess statistical convergence across published neuroimaging studies are needed to determine which brain regions most consistently show cannabis-related alterations.
Neuroimaging meta-analytic tools present opportunities to quantitatively synthesize and more fully interpret published neuroimaging results. As such, we sought to determine which brain regions most consistently demonstrate functional alterations among cannabis users (across various neuroimaging tasks) by examining published findings within the activation likelihood estimation (ALE) framework (Eickhoff et al., 2009; Laird et al., 2005; Turkeltaub et al., 2002) . To do so, we first identified studies reporting functional brain differences between cannabis users and non-users using fMRI or PET in the context of cognitive, social cognitive, affective, perceptual, and motor tasks. This holistic approach permitted the consideration of an expanded experiment assortment, enhancing statistical power, and revealing cannabis-related neurobiological effects irrespective of ontological task classifications . In a primary assessment, we identified convergent cannabis-related activity decreases (users < non-users) and increases (users > non-users) across functional neuroimaging studies. In a first ancillary assessment, we then determined the brain networks in which cannabisaffected regions were embedded using meta-analytic connectivity modeling (MACM). MACM delineates those brain areas that tend to co-activate with user-specified 'seed' regions across various task classifications, revealing potential network-level targets of drug-related effects. In a second ancillary assessment, we aimed to provide enhanced insight into brain-behavior relationships. Specifically, we performed a functional decoding assessment using data from a large repository of published neuroimaging coordinates and associated meta-data terms (BrainMap, http:// www.brainmap.org) to characterize psychological processes potentially linked to functional alterations among cannabis users via quantitative forward-and reverse-inference analyses. Here, we use the term 'functional decoding' to represent the statistical approaches used to determine which psychological processes (e.g. working memory) are implicated given the observed metaanalysis results. This approach provides objective interpretations about the potential behavioral consequences of the convergent neurobiological alterations associated with cannabis use. We anticipated that users would demonstrate region-specific differential activation relative to non-users across brain regions. Moreover, we expected these neurobiological alterations to be associated with expansive task-based neural networks, and to correspond with distinct psychological constructs and processes. Clarifying cannabis's effects on specific brain regions, delineating broader brain networks potentially impacted, and characterizing psychological processes that may be disrupted among users may provide a more complete and coherent understanding of the health-related impacts of cannabis.
Methods and materials

Literature search and selection
We conducted a comprehensive literature search to locate neuroimaging studies that reported brain activation differences between cannabis users and non-users. Primary searches were conducted using PubMed (www.ncbi.nlm.nih.gov/pubmed) and Web of Science (http://webofknowledge.com) with the search terms: MRI OR magnetic resonance imaging OR fMRI OR functional magnetic resonance imaging OR PET OR positron emission tomography OR neuroimaging AND cannabis OR marijuana. To expand our assemblage, we then reviewed the reference sections from the papers identified in the primary search as well as from several narrative reviews (Bhattacharyya et al., 2012a (Bhattacharyya et al., , 2012b Bhattacharyya and Sendt, 2012; Bossong et al., 2014; Chang and Chronicle, 2007; Kowal et al., 2013; Martin-Santos et al., 2010; Wrege et al., 2014) .
The current meta-analysis included studies that: (1) described between-group brain differences between cannabis users and non-users, (2) used fMRI and/or PET measures to derive these differences, (3) expressed differences as statistical parametric contrasts, encompassing the whole brain, with coordinates reported in standard stereotaxic space, and (4) utilized cognitive, social cognitive, affective, perceptual, and/or motor tasks. As a consequence, studies that assessed anatomical differences (e.g. voxel-based morphometry), functional resting-state differences, functional connectivity differences, and/or findings derived using ROI methods were excluded. Moreover, the current metaanalysis was limited to contrasts between cannabis users and non-users, omitting contrasts involving groups specifically selected for having mental health disorders and diseases. Published papers that examined one or more clinical groups (e.g. schizophrenia, bipolar disorder) were carefully reviewed using the inclusion/exclusion criteria. We note that although some studies reported results from several group-level comparisons (e.g. schizophrenia patients with cannabis-use histories > non-schizophrenia patients with cannabis-use histories > controls), coordinate extraction was restricted to just those comparisons between otherwise normal users and non-users (e.g. non-schizophrenia patients with cannabis-use histories > controls). In addition, pharmacologic assessments characterizing acute cannabis administration were not considered. This meta-analysis reflects papers published through December 2016.
Coordinates that expressed decreased activation were taken from contrasts that reported attenuated activation among cannabis users compared with non-users (cannabis users < non-users), while increased activation coordinates were taken from contrasts that reported enhanced activation among users compared with non-users (cannabis users > non-users) . Considering decreased and increased activation across included studies is common among neuroimaging meta-analyses (Cortese et al., 2016; Dehghan et al., 2016; Etkin and Wager, 2007; Radua et al., 2012) . This approach can produce detailed interpretations about neurobiological differences reported across sampled studies. Moreover, by incorporating coordinates across task classifications , we allowed our meta-analytic outcomes to represent more general aspects of task-based processing. That is, results reported here may represent cannabis-related functional brain changes that supersede task-specific and domainspecific demands, revealing neurobiological consequences that are not constrained by variable neuroimaging ontologies and methodologies.
Primary assessment: ALE meta-analysis
To establish which brain regions showed consistent cannabisrelated changes across functional neuroimaging studies, we conducted two coordinate-based ALE meta-analyses using GingerALE (version 2.3.6; http://brainmap.org/ALE/), which implements an updated version of the ALE algorithm (Eickhoff et al., 2009 (Eickhoff et al., , 2012 . ALE meta-analysis is used to assess statistical convergence across results from reported neuroimaging studies (Turkeltaub et al., 2002) , producing quantitative outcomes that are otherwise unobtainable using more traditional narrative review approaches (Laird et al., 2005) . In ALE, activation coordinates (foci) are modeled as centers of three-dimensional Gaussian probability distributions to account for uncertain variance associated with functional neuroimaging experiments. The extent of the aforementioned distribution is weighted using the given experiment's sample size. The GingerALE software computes one modeled brain activation map per experiment, and then aggregates these maps to compute spatial convergence. The resulting ALE map provides statistical measures, via the ALE statistic, for every voxel in the brain, characterizing the extent to which that voxel is implicated in a given dataset. First, we assembled coordinates of cannabis-related decreased and increased activation into a database along with associated experimental characteristics as described elsewhere (detailed description of BrainMap taxonomy and workflows provided in Laird et al., 2009a) (Figure 1 ). This included relevant meta-data, including: experiment sample size, mean subject age, sex distribution, time since last cannabis-use episode, mean lifetime cannabis-use episodes, and task classification or paradigm used. Coordinates that were reported in Montreal Neurological Institute (MNI) space were transformed to Talairach space (Lancaster et al., 2007) . These coordinates were then used to compute two distinct ALE meta-analysis maps, revealing clusters of convergent cannabisrelated decreased activation and increased activation (p cluster-corrected < 0.01; p voxel-level < 0.001) . When considering decreased activations, clusters >3600 mm 3 survived cluster-level thresholding, while for increased activations, clusters >2960 mm 3 survived thresholding. We note that one inherent limitation of ALE meta-analysis is that the approach cannot consider null results (i.e. no observed activation differences between users and non-users). Thus, included studies do not represent the complete corpus of available cannabis-related neuroimaging studies, but rather the corpus of available studies that reported activation differences between users and non-users. Resultant meta-analytic clusters were reported as coordinates in Talairach space. Extrema labels were determined via the Talairach Daemon application (Lancaster et al., 1997 (Lancaster et al., , 2000 . To facilitate future research, ROIs created using resultant meta-analytic clusters have been made available via NeuroVault (http://neurovault.org/ collections/2508).
Ancillary assessment: MACM
To delineate the large-scale brain networks in which cannabisaffected regions were embedded, we used MACM and computed whole-brain co-activation patterns for each resultant ALE metaanalysis cluster. MACM leverages the BrainMap database (www. brainmap.org), an online repository of human neuroimaging studies and associated meta-data, to determine which regions coactivate with a given user-specified seed region (Cauda et al., 2012; Clos et al., 2013; Eickhoff et al., 2011; Robinson et al., 2010 Robinson et al., , 2012 . Results from published functional neuroimaging studies are archived in the database using a rigorous classification scheme and taxonomy that describes peak-activation coordinates in the context of experimental conditions used to derive them (for a complete listing of meta-data terms, please see http://www.brainmap.org/scribe/BrainMapLex.xls). Using Sleuth (version 2.4; www.brainmap.org/sleuth), we searched the database for studies that reported foci within the resulting metaanalysis clusters (i.e. seed regions). Sleuth is an online application that searches the BrainMap database for relevant studies, given user-specified search parameters. Inclusion was limited to databased statistical contrasts that reported activations (i.e. task > baseline) and normal mapping (i.e. non-patient populations), as described in (Robinson et al., 2010 (Robinson et al., , 2012 . At the time of analyses, the database contained 116,639 foci from 3026 papers, representing functional neuroimaging data from more than 60,000 subjects. Contrasts that reported coordinates within the seed regions were extracted from the database and assessed for statistical convergence using ALE meta-analysis to establish each cluster's whole-brain co-activation pattern (p cluster-corrected < 0.01 p voxel-level < 0.001). MACM maps were computed in Talairach space.
Ancillary assessment: Functional decoding
To quantify potential psychological, physiological, or behavioral processes associated with each meta-analysis cannabis-affected cluster, we used a data-driven forward-and reverse-inference analytic approach that capitalizes on the BrainMap database's meticulous classification protocol (Cieslik et al., 2013; Laird et al., 2015; Nickl-Jockschat et al., 2015) . Forward inference describes the likelihood that a specific volume (e.g. voxel, anatomically-defined region, network) will activate given the recruitment of mental processes (e.g. working memory, fear, finger tapping), while reverse inference describes the likelihood that various mental processes are being recruited given activation within some volume. Together, these techniques provide important information about brain-behavior relationships (Yarkoni et al., 2011) . Here, we used intact primary meta-analysis cluster volumes to search the database, effectively circumventing error or bias associated with creating three-dimensional ROIs centered around local maxima. In addition, forward-and reverse-inference analyses were constrained to foci from databased studies that reported activations -as opposed to deactivations -from otherwise normal subjects. Having identified these studies, we examined the distribution of meta-data terms used to catalog them, including various task classifications (e.g. Stroop Task, Monetary Incentive Delay, Flashing Checkerboard). To establish statistical significance, we examined the relations between the representation of meta-data terms contributing to the (a) volume and (b) complete database (Poldrack, 2006; Yarkoni et al., 2011) . That is, we used forward inference to examine the relations between the conditional probability of activation (P(Activation|Process)) and the baseline probability of activation (P(Activation)) being observed within each meta-analytic cluster (p FDR-corrected < 0.05). For forward inference, statistical significance was calculated using a binomial test. These measures (i.e. P(Activation), P(Process), and P(Activation|Process)) were then used to calculate reverse inference (P(Process|Activation)) using Bayes' rule (p FDR-corrected < 0.05). For reverse inference, statistical significance was calculated using a Chi-square test. When considering functional decoding interpretations, we note that subject-level inferences about psychological processes that may be impacted Step 1 (literature search): Published papers that reported functional brain alterations among cannabis users relative to non-users were identified.
Step 2 (primary meta-analysis): Statistical convergence among reported coordinates was assessed using GingerALE to produce separate maps delineating regions showing decreased activations (users < non-users) and increased activations (users > non-users).
Step 3 (connectivity modeling): Using the BrainMap database, MACM was implemented to locate archived neuroimaging experiments that reported co-activations with resultant meta-analytic clusters.
Step 4 (functional decoding): Quantitative forwardand reverse-inference analysis techniques were applied to determine which commonly used functional neuroimaging paradigms were associated with cannabis-affected regions.
ALE: activation likelihood estimation; MACM: meta-analytic connectivity modeling.
among cannabis users (e.g. working memory) are made using modern machine learning techniques that leverage cross-validation to make out-of-sample generalizations (Bzdok and Yeo, 2017; Yarkoni and Westfall, 2017) . These analytic approaches produce models with better predictive value, providing augmented understanding about the relationship between brain regions and associated psychological processes.
Results
Our systematic search yielded 35 peer-reviewed papers meeting inclusion criteria (Table 1; Figure 1 ). The corpus of published results included 88 task-based statistical contrasts, reporting 202 coordinates representing decreased activation among 472 cannabis users and 466 non-users, as well as 161 coordinates representing increased activation among 482 cannabis users and 434 non-users.
Cannabis-related functional alterations
Regarding the neurobiological impact of cannabis use, our primary meta-analytic assessments revealed convergent decreased and increased activation among cannabis users versus nonusers across neuroimaging studies (Table 2; Figure 2) . Specifically, clusters of convergent decreased activation were observed among cannabis users in the bilateral ACC (volume = 4920 mm 3 ) and right DL-PFC (volume = 3744 mm 3 ). In contrast, one cluster of convergent increased activation was observed among cannabis users in the right striatum (i.e. caudate, claustrum, putamen) extending into the insula (volume = 4200 mm 3 ). We note that simultaneous inspection of decreased and increased activation clusters via conjunction analysis revealed no regions of spatial overlap among clusters, suggesting that our meta-analytic results speak to dissociable effects of cannabis use on the brain. Given considerable variance across included studies with respect to time since last cannabis-use episode (Table 1) , we completed an exploratory assessment that involved parsing included studies into two groups: studies reporting short-term and long-term abstinence among users (see Supplemental Figure 1 ).
MACM of affected brain regions
In a first ancillary assessment, we used the BrainMap database to delineate which brain regions tend to co-activate with the cannabisaffected meta-analytic clusters described above (Figure 3 ; Supplemental Table 1 ). MACM analyses revealed that Cluster 1 (ACC) was characterized by extensive whole-brain co-activation patterns, including associations with the insular cortex and caudate, medial frontal cortex, precuneus, fusiform gyrus, culmen, thalamus, and cingulate cortex (Figure 3, top row) . In addition, Cluster 2 (DL-PFC) demonstrated considerable co-activation with the orbitofrontal cortex, parietal regions, fusiform gyrus, and occipital cortex (Figure 3, middle row) . Finally, Cluster 3 (striatum) was associated with whole-brain co-activations that included the insular cortex, frontal cortex, superior parietal lobule, fusiform gyrus, and culmen ( Figure 3, bottom row) . These MACM outcomes demonstrate that cannabis-affected brain regions interact with broader brain networks across various neuroimaging tasks. Moreover, close inspection of each co-activation network suggested considerable spatial overlap within the medial frontal cortex, lateral frontal cortex, lateral parietal regions, insula, and limbic areas.
Functional decoding of primary metaanalytic clusters
In a second ancillary assessment, we used quantitative forward-and reverse-inference analyses to characterize which psychological phenomena were linked to those regions showing cannabis-related functional alterations. Because we were interested in describing the likelihood that mental processes were being recruited given activation in specified brain regions, the results from the reverse-inference analysis are reported in Figure 4 . However, those results from the forward-inference analysis can be found in Supplemental Table  2 
Discussion
To clarify the neurobiological impact of cannabis use, we compiled results from 35 task-based functional neuroimaging papers, which compared cannabis users and non-users, within the ALE meta-analysis framework. In a primary meta-analytic assessment, we identified statistical convergence of reported decreased activation (users < non-users), revealing functional alterations in the ACC and DL-PFC, and of increased activation (users > non-users), showing convergent disruptions in the striatum. In two ancillary assessments, we used archived functional neuroimaging coordinates and associated meta-data to more thoroughly characterize these metaanalytic outcomes. Specifically, we observed co-activation between the ACC and frontal, parietal, and limbic system regions, with demonstrated associations to cognitive, inhibitory, and pain processing tasks. Additionally, the DL-PFC was characterized by co-activation patterns with frontal, parietal, and occipital regions, and was linked to tasks involving cognitive and visual processes. Finally, we observed extensive co-activation between the striatum and frontal, parietal, and limbic regions, and associations to tasks involving reward, inhibition, and pain.
Overall neurobiological impact of cannabis use
Aberrant ACC activation among cannabis users is perhaps not surprising, given the known architecture of the endocannabinoid system. Indeed, several studies have shown dense concentrations of endogenous cannabinoid (CB1) receptors within the ACC (Eggan and Lewis, 2007; Glass et al., 1997; Herkenham et al., 1990 Herkenham et al., , 1991 Svizenska et al., 2008) . Despite these concentrations, findings regarding structural alterations within the ACC among users are mixed (Cousijn et al., 2012a; Weiland et al., 2015) . A critical region in task-dependent and task-independent, or resting-state, processes (Binder et al., 1999; Laird et al., 2009b; Mazoyer et al., 2001; Shulman et al., 1997) , the ACC has been linked to error monitoring, conflict detection, and engaging the DL-PFC to resolve such conflicts (Botvinick et al., 2004; Carter et al., 1998; Carter and van Veen, 2007; Laird et al., 2005) . Increased activation within the ACC, specifically following high-conflict challenges, is thought to promote enhanced DL-PFC activation to reduce conflict and error commissions on subsequent challenges (Kerns et al., 2004) . In this way, the ACC, working in concert with the DL-PFC, is believed to modulate cognitive control processes following high-conflict situations including error detection. Furthermore, the DL-PFC is involved in sustained attention, important for maintaining sensory, motor, and cognitive information 'online' for subsequent encoding and retrieval (Miller and Cohen, 2001 ). Our primary meta-analytic results identified convergent cannabis-related decreased activation in the ACC and DL-PFC. One interpretation of these outcomes is Across studies, cannabis use was associated with differential regional alterations. Specifically, convergent decreases in activity among users were observed in two clusters, one encompassing the cingulate gyrus, anterior cingulate gyrus, and medial frontal gyrus (Cluster 1 (ACC), blue), and a second encompassing the middle frontal gyrus and precentral gyrus (Cluster 2 (DL-PFC), blue). Conversely, convergent increases in activity among users were observed in a single cluster encompassing the caudate, claustrum, putamen, and extending into the insula (Cluster 3 (Striatum), red). ALE maps were computed in Talairach space and thresholded (p cluster-corrected < 0.01; p voxel-level < 0.001). Labels and numbering correspond with those in Table 2 . Reverse-inference analysis characterized psychological processes that were significantly associated with functionally impacted brain regions among cannabis users. Meta-data term associations were visualized using Cytoscape version 3.4.0 (Shannon et al., 2003) . Lines between meta-data terms (squares, task classifications) and meta-analytic clusters (circles, impacted brain regions) indicate that the observed probability reached statistical significance. Probabilities next to each line (p FDR-corrected < 0.05) express the likelihood that a specific psychological process is engaged given activation in a specified brain region (P(Process|Activation)), where higher values indicated greater likelihoods.
ACC: anterior cingulate cortex; DL-PFC: dorsolateral prefrontal cortex.
that functional alterations within cognitive control nodes and their associated brain networks may underlie task-performance disruptions among cannabis users. Indeed, several studies have reported poorer performance among users relative to non-users when considering tasks which probe cognitive control and executive functions (e.g. Crane et al., 2013a Crane et al., , 2013b Gruber and Yurgelun-Todd, 2005; Sagar et al., 2015; Thames et al., 2014) . Results from our functional decoding assessments are consistent with such accounts, suggesting that the ACC and DL-PFC were associated with behavioral control paradigms, including Flanker and Stroop Tasks, and with paradigms involving learning and memory, including Delayed Match to Sample and Recitation/Repetition (Figure 4 , DL-PFC, purple). Mesocorticolimbic and nigrostriatal dopaminergic systems are implicated in various aspects of reward processing, including evaluating social judgments Kampe et al., 2001) , and substance use (Delgado, 2007; Haber and Knutson, 2010; Wise, 2009) . Specifically, drug-related hyperactivation throughout dopaminergic circuitry, including the striatum, has been linked to longterm substance use across various drugs, including opioids (Chu et al., 2015) , heroin (Li et al., 2012) , alcohol (Gilman et al., 2012; van Holst et al., 2014) , cocaine (Jia et al., 2011 ), amphetamines (O'Daly et al., 2014 , nicotine (Addicott et al., 2012) , and cannabis (Abdullaeva et al., 2010; Acheson et al., 2015; Cousijn et al., 2012a; Enzi et al., 2015; Hester et al., 2009; Nestor et al., 2010; van Hell et al., 2010) . Our meta-analytic results are consistent with these reports, as we observed increased activation within the striatum among cannabis users. In addition, functional decoding revealed an association between the striatum and the task classification of Reward, suggesting that users may demonstrate cannabis-related enhanced activation in brain regions that subserve reward processing. These conclusions are supported by previous accounts that link the striatum to reward-processing features, including anticipation and appraisal (Delgado, 2007; Haber and Knutson, 2010; Wise, 2009) . Indeed, increased reward-seeking behavior following cannabis exposure has been demonstrated in animal (for an extensive review, see Tanda and Goldberg, 2003) and human studies (Gilman et al., 2015; Lyvers et al., 2013) . Moreover, a large-scale longitudinal assessment of adolescent risky decision-making found that increased substance use, including cannabis, correlated with attentional biases towards reward-predictive cues (van Hemel-Ruiter et al., 2013) . However, across drugs of abuse, both decreased and increased striatal responding has been reported during reward anticipation. Regarding cannabis, such discrepant outcomes may reflect distinct methodological decisions made across studies. For example, one study (van Hell et al., 2010) , which required cannabis-using participants to have a negative THC urine toxicology screen before scanning, reported comparable striatal activity during reward anticipation relative to non-users. In another study (Nestor et al., 2010) , in which users were required to have a positive THC toxicology screen, cannabis-using participants showed increased striatal activity despite similar task demands as in the previous example. As such, it is plausible that these seemingly discordant results are indicative of residual intoxication/pharmacological effects among users with positive toxicology results (Balodis and Potenza, 2015) . Nevertheless, the convergent increased striatal activation observed among users here, coupled with quantitatively demonstrated associations to reward-related tasks, provides a potential neurobiological explanation for previously characterized links between cannabis use and sensitization towards reward-predicting cues and associated outcomes.
The evolution from recreational substance use to dependence is believed to represent a transition from cortical-mediated to striatal-mediated behavioral control processes (Volkow et al., 2013) . For example, functional neuroimaging studies have shown decreased activations in the ACC and PFC among cocaine users; deficits that persisted more than 3 months following detoxification (Volkow and Wang, 1992) . Such alterations in cognitive control neurocircuitry have been linked to impulsive behaviors (Holmes et al., 2016) . Taken together, decreased activation of the ACC and DL-PFC, paired with increased activation of the striatum, may represent a systems-level neurobiological mechanism through which problematic, and potentially addictive cannabis use patterns develop. From a related perspective, it is noteworthy that each of the three meta-analytic clusters observed were associated with the Go/No-Go task classification, a behavioral inhibition paradigm requiring participants to make/withhold motor responses. These results are consistent with contemporary views about the relations between the PFC, striatum, and one's abilities to regulate problematic behaviors (Goldstein and Volkow, 2011) . Here, the fact that distinct region-specific disruptions were linked with the same task classification may be indicative of a cannabisrelated compound effect manifest across studies. In other words, a diminished capacity to inhibit problematic behaviors may be linked to concurrent reduction of prefrontal activity (ACC and DL-PFC) and elevation of striatal activity.
Implications from functional decoding
Given the absence of pain-related studies in this meta-analysis, it is noteworthy that two clusters, the ACC and striatum, were linked with the pain monitor/discrimination meta-data task classifications (Figure 4) . Indeed, these structures have demonstrated involvement in distinct aspects of pain processing (Freund et al., 2009; Jahn et al., 2016; Lieberman and Eisenberger, 2015) . From a pharmacotherapy perspective, cannabinoids represent a potential option for pain treatment and management. Data from more than 40 clinical trials using cannabinoids provide evidence for its antinociceptive effects in both chronic and neuropathic pain (Hill, 2015) . A recent meta-analysis explored the beneficial and adverse effects of cannabinoids for medical use (Whiting et al., 2015) . When considering data from 79 studies, representing 6462 participants, those researchers found a 37% pain reduction among medicinal cannabis users. Despite these and other findings, the antinociceptive properties of cannabis remain poorly understood at the neurobiological level. Results from one pharmacologic neuroimaging investigation involving cannabis administration suggest that a potential mechanism for THCrelated analgesic effects may be through cingulate-limbic connectivity (Lee et al., 2013) . Our meta-analytic outcomes and subsequent functional decoding results demonstrate the utility of using meta-analytic approaches to coalesce results from published neuroimaging studies involving substance use, revealing neuroimaging paradigms that may warrant additional investigation among cannabis-using populations (e.g. pain processing).
Limitations
When interpreting these results, we considered several methodological issues. First, the observed meta-analytic effects of cannabis should be considered preliminary, given the sample of studies included (N = 35). In addition, similar limitations barred the meta-analytic assessment of structural differences (e.g. voxel-based morphometry), acute cannabis effects (e.g. drugadministration studies), and null effects (i.e. studies reporting no differences between users and non-users). Second, as is the case with most reviews and meta-analytic reports, our results are constrained by the current state of the functional neuroimaging literature. Studies included here used tasks designed to probe specific psychological constructs, such as working memory, spatial memory, reward processing, and response inhibition. Importantly, the range of tasks used to identify use-related functional brain alterations may be constrained by a priori conceptualizations about cannabis's impact on brain and behavior. That is, it is possible that the findings reported here reflect an overabundance of cognition-and reward-related investigations, and that the inclusion of more affective, perceptual, or motor investigations would refine the current results, revealing alternative brain regions that may be impacted among cannabis users. Third, the studies included in this meta-analysis were all cross-sectional, which limits causal inferences that can be made about the observed functional brain alterations and cannabis use. With large-scale longitudinal assessments currently underway, such as the Adolescent Brain Cognitive Development study, dissociable antecedents and consequences of cannabis use will become more evident. Fourth, we note that these findings represent cannabis-related decreased and increased activation that are task-general. The included studies represent the expanding corpus of functional neuroimaging studies on cannabis use that used fMRI or PET, and reported whole-brain findings. As new neuroimaging data are assembled, a more dissociative approach should become possible, permitting assessment of task-specific effects (e.g. cannabis users versus non-users during working-memory challenges). Fifth, the studies included here did not adequately consider sex-specific effects of cannabis use on brain function. Specifically, women were under-sampled among included studies, with 79% of users and 73% of non-users being men. Additionally, whole-brain contrasts comparing men and women are sparse, despite emerging indications of sex-specific effects. For example, one recent report showed that men, but not women, were responsive to the antinociceptive effects of cannabis, showing significant reductions in pain sensitivity (Cooper and Haney, 2016) . Similar sex differences have also been reported regarding neurocognitive performance (Crane et al., 2013a (Crane et al., , 2013b . Future studies should take into consideration potential sex differences when assessing the neurobiological effects of cannabis. Finally, cannabis-use assessment, including amount and frequency estimates, as well as duration since last cannabis-use episode, varied across the included studies. Despite considerable variance regarding these measures, with some studies reporting recreational use and others reporting more severe, problematic use patterns, convergent results were indeed detected. Furthermore, an exploratory assessment that involved parsing included studies using abstinence measures revealed distinct neurobiological changes associated with short-term versus long-term durations since last use episode (Supplemental Figure 2) . Future investigations should take into consideration these critical factors to provide additional clarification regarding the impact of the amount, frequency, and currency of cannabis use on brain function.
Conclusions
The meta-analytic outcomes reported here suggest that cannabis use is linked with differential, region-specific effects on the brain, including decreased activation in the ACC and DL-PFC, and increased activation in the striatum. Ancillary analyses revealed that these cannabis-related functional alterations were embedded within expansive co-activation networks, and that several psychological processes may be impacted among users. Specifically, these functional alterations may manifest as alterations in cognitive control performance, enhanced reward seeking and responsiveness, and disrupted pain processing. This study highlights the utility of using meta-analytic tools to synthesize published neuroimaging results thereby elucidating neurobiological, cognitive, and behavioral processes associated with cannabis use. As policies and societal norms regarding cannabis undergo rapid changes, enhanced understanding of the impact of cannabis on the human brain is important for providing patients, healthcare providers, and policy makers with scientific information allowing for informed decision-making regarding cannabis use.
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